Translational and experimental ophthalmology bridges the gap between laboratory research and clinical practice, turning scientific discoveries into practical treatments. By focusing on innovative research, this field seeks to translate basic science into real-world applications, offering new treatments for ocular diseases such as retinal degeneration, corneal disorders, and optic neuropathies. Advances in gene therapy, stem cell research, and novel drug delivery systems are among the key areas driving progress. This research is crucial for improving treatments for conditions like age-related macular degeneration, where conventional therapies often fall short. Translational efforts are not only focused on developing new therapies but also on optimizing current treatment protocols to improve patient outcomes. The ultimate goal is to improve patient care by integrating cutting-edge scientific findings into clinical practice, offering hope for individuals with conditions that were once considered untreatable.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom